motavizumab

Showing 1 posts of 1 posts found.

AstraZeneca takes $445m hit to halt motavizumab

December 22, 2010
Research and Development AZ, AstraZeneca, MedImmune, motavizumab, respiratory, respiratory syncytial virus

AstraZeneca has withdrawn a US licence application for its biologic respiratory treatment motavizumab in a move that will cost the …

The Gateway to Local Adoption Series

Latest content